Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and HANDLE® technologies, AmoyDx has a market-leading portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx’s core product categories including but not limited to single gene testing kits, multi-gene testing panels, NGS panels and NGS analytical systems. In the past years, more than 20 diagnostic kits have been approved by the Chinese authorities, the NMPA and in Europe (CE mark). In several External Quality Assessment (EQA) programs, including EMQN and PQCC, AmoyDx is the NO. 1 testing kit supplier for years and always achieves the highest accuracy rates. Nowadays, AmoyDx serves an extensive domestic and international oncology network, reaching over 500 top hospitals in China and over 50 countries worldwide. Every year hundreds of thousands of cancer patients benefit from AmoyDx products and services. As diagnostic partner with AstraZeneca, Amgen, Boehringer-Ingelheim, Johnson & Johnson, Eli Lilly, Illumina, Merck and Pfizer, AmoyDx provides diagnostic products and services for trials of drugs in clinical development and for clinical practice. AmoyDx® ROS1 kit was the first approved companion diagnostic kit for Pfizer's crizotinib by Japanese and South Korean authorities. Our mission is to improve healthcare and patients’ lives with superior & innovative products and services. Our vision is to be one of the global leading and most reliable suppliers of quality diagnostic products and services for personalized healthcare. We endeavor to accomplish this mission and vision by: 1. Adhering strictly to manufacturing standards to provide quality products. 2. Maintaining an unsurpassed level of customer experience and satisfaction. 3. Pursuing scientific innovation to provide customers with practical leading-edge technologies and value-added products. 4. Creating a world-class organization that contributes positively to the lives of our employees, our customers, the patients and the scientific community.